Core Insights - Intuitive Surgical has seen a bearish sentiment from large investors, with 61% of trades being bearish and only 38% bullish [1] - The predicted price range for Intuitive Surgical's stock is between $480.0 and $650.0 over the last three months [2] - Recent options activity indicates significant interest in both call and put options, with a total of $251,378 in puts and $463,576 in calls detected [1] Options Activity - A total of 13 trades were detected, with 6 puts and 7 calls, indicating a mixed sentiment among investors [1] - Significant options trades include a bullish call with a total trade price of $108.0K at a strike price of $580.00 and a bearish call with a total trade price of $48.1K at a strike price of $650.00 [8] - The volume and open interest trends for options within the $480.0 to $650.0 strike price range have been monitored over the last 30 days, indicating liquidity and interest [3] Company Overview - Intuitive Surgical develops and markets a robotic system for minimally invasive surgery, with over 10,000 da Vinci systems installed globally [9][10] - The company has a strong presence in the U.S. with more than 6,000 installations and is expanding in emerging markets [9] Analyst Ratings - Analysts have issued a consensus target price of $569.2 for Intuitive Surgical, with individual targets ranging from $525 to $603 from various firms [11][12] - Truist Securities, BTIG, Raymond James, and Wells Fargo have all maintained positive ratings on the stock, indicating confidence in its future performance [12] Current Market Performance - The current trading volume for Intuitive Surgical is 514,806, with the stock price at $575.68, reflecting a slight decrease of -0.09% [14] - Current RSI values suggest that the stock may be overbought, indicating potential caution for investors [14]

Core Insights - Intuitive Surgical's stock has surged over 15% following strong Q3 results and positive guidance, reflecting rising demand for robotic-assisted surgical systems [1] Financial Performance - Q3 sales reached $2.5 billion, up from $2.03 billion year-over-year, exceeding estimates of $2.41 billion [2] - Revenue from instruments and accessories grew by 22%, indicating higher procedure volume and increased utilization per system [2] - Earnings per share (EPS) increased by 30% to $2.40, surpassing Q3 EPS expectations of $1.99 by 20% [3][4] Operational Highlights - Intuitive Surgical has exceeded earnings expectations for 11 consecutive quarters, with an average EPS surprise of 16.34% in the last four quarters [3][4] - There was a 20% increase in global surgeries using da Vinci robotic systems, enhancing precision in minimally invasive surgeries [5] - The company placed 427 da Vinci systems in Q3 2025, compared to 379 in the same quarter last year [7] Strategic Outlook - Full-year da Vinci procedure growth expectations have been raised to 17%-17.5% from 15.5%-17% [9] - Pro forma gross margin projections for the full year have been increased to 67%-67.5% from 66%-67% [9] - Total sales are expected to rise by 18% this year and another 12% in fiscal 2026, reaching $11.12 billion [10] Market Position - Intuitive Surgical has expanded its installed base to over 10,000 systems, enhancing recurring revenue from instruments and accessories [12] - The stock currently trades at a premium of 64X forward earnings, with potential for a buy rating if the rally continues [11]